Hepatitis C – Vanishing Disease? - Sammy Saab, MD, MPH | UCLA Digestive Diseases

Hepatitis C – Vanishing Disease? - Sammy Saab, MD, MPH | UCLA Digestive Diseases

UCLA Health via YouTube Direct link

Model-Based Predictions The Changing Burden of Hepatitis C Virus Infection

19 of 20

19 of 20

Model-Based Predictions The Changing Burden of Hepatitis C Virus Infection

Class Central Classrooms beta

YouTube videos curated by Class Central.

Classroom Contents

Hepatitis C – Vanishing Disease? - Sammy Saab, MD, MPH | UCLA Digestive Diseases

Automatically move to the next video in the Classroom when playback concludes

  1. 1 Intro
  2. 2 Decreasing Prevalence of Chronic Hepatitis C Infection, NHANES 2003 to 2010
  3. 3 Increasing Number of Hospitalizations related to HCV in Los Angeles County, 2007-2009
  4. 4 Extrahepatic Manifestations of Chronic Hepatitis C
  5. 5 Evolution of Hepatitis C Therapy Genotype 1
  6. 6 Hepatitis C: Achieving a Cure
  7. 7 Properties of Direct Acting Agents
  8. 8 Combination of Direct Acting Agents
  9. 9 Disappearing Special Populations
  10. 10 Cure vs Relapse Great Balance Act
  11. 11 Special Considerations
  12. 12 Resistance Associated Variants (RAV) General Principles
  13. 13 Resistance Testing
  14. 14 Treatment Regiments for Genotype 1 Patients
  15. 15 Treatment of non-Genotype 1 Patients
  16. 16 Grazoprevir and Elbasvir in Patients with Stage 4 or 5 Chronic Kidney Disease
  17. 17 Recommended Monitoring for patients after Antiviral Treatment
  18. 18 Improving the HCV Test and Cure Continuum: High Drug Costs are Not the Only Barrier
  19. 19 Model-Based Predictions The Changing Burden of Hepatitis C Virus Infection
  20. 20 Changes in CPT and MELD Scores from Baseline.

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Someone learning on their laptop while sitting on the floor.